Pathologic Complete Response Rates of Patients with ER-low/HER2-negative Breast Cancer Treated with Neoadjuvant Pembrolizumab Plus Chemotherapy in the Neo-Real Study Renata Colombo Bonadio , Monique Celeste Tavares , Flávia Cavalcanti Balint , Isadora Martins de Sousa , Ana Carolina Marin Comini , Fernanda Madasi , Jose Bines , Rafael Dal Ponte Ferreira , Daniela Dornelles Rosa , Candice Lima Santos , Zenaide Silva de Souza , Daniele Assad-Suzuki , Júlio Antônio Pereira de Araújo , Débora de Melo Gagliato , Carlos Henrique dos Anjos , Bruna M. Zucchetti , Anezka Ferrari , Mayana Lopes de Brito , Renata Cangussu , Maria Marcela Fernandes Monteiro , Paulo M. Hoff , Laura Testa , Maria del Pilar Estevez-Diz , Romualdo Barroso-Sousa Breast Cancer Research and Treatment（2025）
关键词
Breast cancer, ER-low, Immunotherapy, Neoadjuvant
AI 理解论文
溯源树
样例
